Paroxetine Hydrochloride

CAS 78246-49-8 17 current records 10 historicalSmall Molecule

Who holds supplier records for Paroxetine Hydrochloride? 17 organisations hold a current record for Paroxetine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Spain (1), Canada (1) and 2 other countries (2); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Paroxetine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/paroxetine-hydrochloride

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Paroxetine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China3Spain1Canada1Italy1Hungary1Country not recorded for 2
Need Paroxetine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Paroxetine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2006-206 - Rev 06
Paroxetine hydrochloride hemihydrate
Jun 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2009-155 - Rev 07
Paroxetine hydrochloride
Jun 2026—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2014-095 - Rev 01
Paroxetine hydrochloride hemihydrate
May 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2009-204 - Rev 03
Paroxetine hydrochloride hemihydrate
Jan 2026—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2004-239 - Rev 07
Paroxetine hydrochloride hemihydrate
Oct 2024—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2003-250 - Rev 02
Paroxetine hydrochloride hemihydrate
Jul 2022—
CHEMI S.P.A. PatricaIT
R1-CEP 2011-188 - Rev 02
Paroxetine hydrochloride hemihydrate
Jun 2020—
Wanbury Limited Vashi, Navi MumbaiIN
R1-CEP 2012-376 - Rev 00
Paroxetine hydrochloride hemihydrate
Mar 2019—
Medichem, S.A. Sant Joan DespíES
R1-CEP 2011-200 - Rev 00
Paroxetine hydrochloride hemihydrate
Mar 2018—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2006-192 - Rev 01
Paroxetine hydrochloride hemihydrate
Jun 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Paroxetine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • United Kingdom · Inactive DMF 24960, 14913 · filed May 2011
  • India · Inactive DMF 19970 · filed Nov 2006
  • TAIZHOU HIGHSUN PHARMACEUTICAL CO LTD
    Inactive DMF 19803 · filed Sept 2006
  • India · Inactive DMF 17286 · filed Apr 2004
  • RECORDATI ESPANA SL
    Inactive DMF 17293 · filed Mar 2004
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 16416 · filed Feb 2003
  • Brazil · Inactive DMF 16247 · filed Nov 2002
  • ASAHI GLASS CO LTD
    Inactive DMF 14432 · filed Sept 1999
  • Japan · Inactive DMF 13888 · filed Dec 1998
  • APOTEX PHARMACHEM INC
    Inactive DMF 12770 · filed Dec 1997

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Paroxetine Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder and a range of anxiety disorders. It improves mood by increasing the levels of serotonin, a natural substance in the brain that helps maintain mental balance.

Chemical identity

IUPAC name
bis((3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine);hydrate;dihydrochloride
Canonical SMILES
C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.O.Cl.Cl
InChIKey
MQZOATSIFWSKKT-OASXIEIISA-N
Synonyms
Paxil API, aropax, brl29060a, deroxat, paroxetine hydrochloride hemihydrate, paroxetine hydrochloride hydrate, paxil, paxil cr, seroxat

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin Reuptake Inhibitor
Mechanism of action
Serotonin Uptake Inhibitors

Therapeutic areas

DepressionAnxiety DisordersObsessive-Compulsive Disorder

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Paroxetine Hydrochloride?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Paroxetine Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), JUBILANT BIOSYS LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), MEDICHEM SA (Spain), WANBURY LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zydus Lifesciences Limited (India) and Apotex Inc. (Canada), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Paroxetine Hydrochloride Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 19152), JUBILANT BIOSYS LTD (DMF 22337), MATRIX PHARMACORP PRIVATE LTD (DMF 38793), MEDICHEM SA (DMF 18052), WANBURY LTD (DMF 20248), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 19922), Zydus Lifesciences Limited (DMF 16680) and Apotex Inc. (DMF 21440) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Paroxetine Hydrochloride records mean?

10 organisations have only inactive Type II DMFs for Paroxetine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Paroxetine Hydrochloride have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Paroxetine Hydrochloride on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), IPCA LABORATORIES LIMITED Mumbai (IN), JUBILANT BIOSYS LIMITED Mysuru (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN) and GEDEON RICHTER PLC. Budapest (HU) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Paroxetine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Paroxetine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.